Barclays PLC Health Catalyst, Inc. Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
A detailed history of Barclays PLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Barclays PLC holds 103,782 shares of HCAT stock, worth $806,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,782
Previous 104,503
0.69%
Holding current value
$806,386
Previous $787,000
15.88%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HCAT
# of Institutions
165Shares Held
50.2MCall Options Held
2.51MPut Options Held
1.8K-
Black Rock Inc. New York, NY5.43MShares$42.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$35.2 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.96MShares$30.7 Million2.3% of portfolio
-
Impax Asset Management Group PLC2.55MShares$19.8 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.41MShares$18.8 Million0.01% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $425M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...